BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $60,651,000 | +19.0% | 932,944 | +33.8% | 0.45% | +2.3% |
| Q2 2020 | $50,960,000 | +71.0% | 697,038 | -20.4% | 0.44% | +37.5% |
| Q1 2020 | $29,800,000 | -9.0% | 875,710 | +45.6% | 0.32% | +12.3% |
| Q4 2019 | $32,739,000 | +684.7% | 601,370 | +501.4% | 0.28% | +650.0% |
| Q3 2019 | $4,172,000 | -36.5% | 100,000 | -33.3% | 0.04% | -34.5% |
| Q2 2019 | $6,569,000 | -7.1% | 150,000 | +9.2% | 0.06% | -12.1% |
| Q1 2019 | $7,068,000 | +27.4% | 137,331 | -8.4% | 0.07% | +11.9% |
| Q4 2018 | $5,547,000 | -29.7% | 150,000 | -24.8% | 0.06% | +25.5% |
| Q2 2018 | $7,888,000 | – | 199,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |